BeStock  
Stocks › CAR-T Therapy › NVS

Novartis AG NVS

US equityMarket cap rank #46CAR-T TherapyCancer Research
$162.55 +$0.62 (+0.38%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $162.55 0.00%
Open$159.40
Prev close$161.93
Day range$159.36 – $163.11
Volume2.00M
Market cap$307.00B
P/E (TTM)31.0
Dividend yield2.92%

Earnings

Average move on report day±2.4%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+4.6%
Worst reaction-4.4%

Stock move on the day after each report

+4.6%2023/Q2+0.2%2023/Q3-4.0%2023/Q4+2.3%2024/Q10.0%2024/Q4+0.7%2025/Q1-3.3%2025/Q2-4.4%2025/Q3+2.0%2025/Q4+0.9%2026/Q1+2.9%2026/Q2+2.0%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q327 Oct 2026None±4.5%+1.98%Within range
2026/Q221 Jul 2026None±5.5%+2.88%Within range
2026/Q128 Apr 2026Pre Market±4.0%+0.91%Within range
2025/Q44 Feb 2026Pre Market±4.5%+2.04%Within range
2025/Q328 Oct 2025Pre Market±3.8%-4.42%Bigger than priced
2025/Q217 Jul 2025Pre Market±4.0%-3.25%Within range
2025/Q129 Apr 2025Pre Market±5.4%+0.73%Within range
2024/Q431 Jan 2025Pre Market±5.6%-0.03%Within range
2024/Q123 Apr 2024None±5.9%+2.27%Within range
2023/Q431 Jan 2024None±4.6%-3.97%Within range
2023/Q324 Oct 2023None±5.1%+0.23%Within range
2023/Q218 Jul 2023None±4.8%+4.57%Within range
2023/Q125 Apr 2023None±4.6%+3.43%Within range
2022/Q41 Feb 2023None±4.0%-2.64%Within range
2022/Q325 Oct 2022None±5.8%+1.03%Within range
2022/Q219 Jul 2022None±5.8%+3.99%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$15.03B+4.7% YoY
Operating profit$1.84B-59.1% YoY
Net profit$1.20B-69.6% YoY
Diluted EPS$0.63-68.8% YoY
Free cash flow$4.76B-17.1% YoY
Operating cash flow$5.50B

Revenue, last 8 quarters

$13.6BDec '24$13.6BMar '25$14.8BJun '25$14.4BSep '25$13.9BDec '25$13.5BMar '26$15.0BJun '26$15.0BSep '26

Net profit, last 8 quarters

$2.8BDec '24$3.6BMar '25$4.0BJun '25$3.9BSep '25$2.4BDec '25$3.2BMar '26$3.3BJun '26$1.2BSep '26

Profitability & balance sheet

Gross margin74.9%
Operating margin25.2%
Net margin17.5%
Return on equity24.6%
Return on assets8.9%
Return on invested capital13.9%
Current ratio0.88
Liabilities / assets67.9%
Cash & investments$8.98B
Total debt$48.03B
Net cash (debt)-$39.06B
Free cash flow / sales24.4%

Discussion

No comments yet — be the first to weigh in on NVS.

Sign in to join the discussion.

Scroll to Top